Market Place
Sourcing Support
Bayer to Share New Data from KERENDIA Trial at Renal Congress
04 Jun 2025 //
BUSINESSWIRE
US FDA Approves Nubeqa to Treat Metastatic Prostate Cancer
03 Jun 2025 //
BUSINESSWIRE
Bayer and BlueRock`s Journey in Cell Therapy Future
02 Jun 2025 //
FIERCE BIOTECH
New XOFIGO Data in Metastatic Prostate Cancer Published
30 May 2025 //
BUSINESSWIRE
ASCO 2025: XOFIGO Combo Data Shows Benefits in Prostate Cancer
28 May 2025 //
BUSINESSWIRE
FDA Reviews NDA for Sevabertinib in HER2+ Lung Cancer
28 May 2025 //
BUSINESSWIRE
Bayer Cell Therapy Plant In California Earns LEED Platinum
28 May 2025 //
INDPHARMAPOST
ASCO 2025: Nubeqa Post-hoc Data on QoL, Pain in mCSPC
27 May 2025 //
BUSINESSWIRE
AskBio Shares Ph1b Results for AB-1005 in Parkinson
27 May 2025 //
GLOBENEWSWIRE
Bayer wins EU watchdog`s Endorsement for Eylea treatment
23 May 2025 //
REUTERS
Bayer Launches Centafore Imaging Core Lab for Clinical Trials
22 May 2025 //
BUSINESSWIRE
Bayer Presents New Data at 2025 ASCO Annual Meeting
21 May 2025 //
BUSINESSWIRE
FDA approves Jivi® for pediatric hemophilia A
19 May 2025 //
BUSINESSWIRE
Bayer head says FDA reassured pharma executives of timely reviews
17 May 2025 //
REUTERS
Bayer seeks Roundup settlement, explores Monsanto bankruptcy
16 May 2025 //
REUTERS
Bayer seeks Roundup settlement, explores Monsanto bankruptcy
15 May 2025 //
REUTERS
Bayer confirms 2025 targets after solid start to the year
14 May 2025 //
INDPHARMAPOST
Bayer weathers LOE for Xarelto with success of Kerendia, Nubeqa
13 May 2025 //
FIERCE PHARMA
Passage of New Georgia Bill a Win for Farmers
12 May 2025 //
BUSINESSWIRE
Bayer US Surveys on Menopause Care Approaches and Symptoms
08 May 2025 //
BUSINESSWIRE
Life Sciences Leaders Unify at Veeva Commercial Summit
06 May 2025 //
PR NEWSWIRE
Galmed: Aramchol Boosts Bayer`s Regorafenib in GI Cancer Models
06 May 2025 //
PR NEWSWIRE
Bayer to exit US seed treatment equipment business, email says
30 Apr 2025 //
REUTERS
Bayer wins appeal in case of ‘warming’ market for Eylea launch
29 Apr 2025 //
FIERCE PHARMA
Guru Ramamurthy Named CFO for Bayer`s Crop Science Division
29 Apr 2025 //
BUSINESSWIRE
Bayer starts Ph I using Actinium-225 on GPC3 in liver Carcinoma
29 Apr 2025 //
BUSINESSWIRE
AUA 2025: NUBEQA® + ADT Shows Strong PSA Response in mHSPC
29 Apr 2025 //
BUSINESSWIRE
Plaintiffs` Attorneys React to Bayer Threat to Pull Roundup
29 Apr 2025 //
BUSINESSWIRE
Guru Ramamurthy named CFO for Bayers Crop Science Division
29 Apr 2025 //
BUSINESSWIRE
Bayer CEO Bill Anderson aims for Profitable Growth
25 Apr 2025 //
INDPHARMAPOST
ConcertAI, Bayer Partner to Accelerate Precision Oncology
22 Apr 2025 //
BUSINESSWIRE
Bayer lobbies US states in battle to keep glyphosate on market
18 Apr 2025 //
REUTERS
Bayer to Present NUBEQA Data at AUA 2025 Meeting
16 Apr 2025 //
BUSINESSWIRE
Bayer Invests $44 Million in Myerstown, PA Facility
16 Apr 2025 //
BUSINESSWIRE
FDA Grants Approval of Vitrakvi for NTRK GeneFusion-Positive Tumors
10 Apr 2025 //
BUSINESSWIRE
Bayer renews bid for US Supreme Court to curb glyphosate cases
04 Apr 2025 //
REUTERS
Bayer files petition to US Supreme Court for Durnell Roundup case
04 Apr 2025 //
BUSINESSWIRE
NPPA asks Bayer Zydus to sell Urografin for one more year
29 Mar 2025 //
PHARMABIZ
Bayer acquires rights in Puhe BioPharma cancer drug candidate
27 Mar 2025 //
REUTERS
Bayer Presents New Heart Failure Data in ACC.25
25 Mar 2025 //
BUSINESSWIRE
400+ Studies Reviewed Over 30 Years
25 Mar 2025 //
BUSINESSWIRE
Dr. Mike Graham Named Head of R&D at Bayer Crop Science
24 Mar 2025 //
BUSINESSWIRE
Bayer hit with $2 B Roundup verdict in Georgia cancer case
24 Mar 2025 //
REUTERS
U.S. FDA Accepts New Indication for Kerendia in Heart Failure
17 Mar 2025 //
BUSINESSWIRE
Bayer Seeks Investor Nod For 35% Cash Call To Cover Litigation
07 Mar 2025 //
REUTERS
Late-Breaking QUANTI CNS Data Presented At ECR 2025
26 Feb 2025 //
BUSINESSWIRE
Bayer Aspirin Promotes Heart Health With “See Their Risks” Campaign
18 Feb 2025 //
BUSINESSWIRE
Bayer files for approval of finerenone in heart failure in Japan
15 Feb 2025 //
INDPHARMAPOST
Nubeqa Data Reinforce Safety & Efficacy In Prostate Cancer
13 Feb 2025 //
BUSINESSWIRE
Bayer Presents Prostate Cancer Data At 2025 ASCO GU Symposium
11 Feb 2025 //
BUSINESSWIRE
Bayer Launches Survey On Global Attitudes Toward Technologies
20 Jan 2025 //
BUSINESSWIRE
Bayer’s pharma growth strategy progressing well as pipeline
15 Jan 2025 //
INDPHARMAPOST
Bayer’s Pharma Growth Strategy Advances With Pipeline Progress
14 Jan 2025 //
BUSINESSWIRE
Bayer moves allogeneic cell therapy into Ph 3 Parkinson`s trial
14 Jan 2025 //
FIERCE BIOTECH
Bayer’s hot flash drug hits goal in phase 3 breast cancer trial
10 Jan 2025 //
PRESS RELEASE
Orion’s partner Bayer in China for 3rd indication of darolutamide
08 Jan 2025 //
PRESS RELEASE
Regeneron to expand high-dose Eylea`s label after Ph 3 win
18 Dec 2024 //
BIOSPACE
Bayer opens Berlin incubator and welcomes first resident
29 Nov 2024 //
PHARMAPHORUM
FDA Accepts NDA in Metastatic Hormone-Sensitive Prostate Cancer
21 Nov 2024 //
BUSINESSWIRE
Bayer acquires rights to Cytokinetics` heart drug in Japan
20 Nov 2024 //
REUTERS
